Consolidated Statements Of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenue:
Product revenue	$ 854,531	$ 816,992	$ 782,654
Service revenue	522,527	476,346	436,035
Total revenue	1,377,058	1,293,338	1,218,689
Cost of Revenue:
Cost of product revenue	318,685	305,910	309,795
Cost of service revenue	302,255	288,280	262,388
Total cost of revenue	620,940	594,190	572,183
Gross profit	756,118	699,148	646,506
Expenses:
Sales and marketing	243,492	216,962	204,850
General and administrative	157,861	137,609	129,389
Research and development	88,003	82,014	76,042
Income from operations	266,762	262,563	236,225
Interest expense	(5,386)	(3,848)	(3,547)
Interest income	1,885	1,902	1,744
Income before provision for income taxes	263,261	260,617	234,422
Provision for income taxes	75,467	82,330	72,668
Net income	187,794	178,287	161,754
Less: Net (loss) income attributable to noncontrolling interest	(6)	20	(32)
Net income attributable to IDEXX Laboratories, Inc. stockholders	$ 187,800	$ 178,267	$ 161,786
Earnings per Share:
Basic	$ 3.53	$ 3.24	$ 2.85
Diluted	$ 3.48	$ 3.17	$ 2.78
Weighted Average Shares Outstanding:
Basic	53,159	54,985	56,790
Diluted	53,985	56,155	58,214